AGT and aneurysm: When compared with the AngII‐infused group, S3KO mice receiving β‐blocker treatment had significantly reduced aortic expansion (Figure 2F), aneurysm severity (Figure 2H), and death rate (5 of 8 mice died) (Figure 5I) but failed to significantly lower aneurysm incidence (Figure 2G).